Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. - Wikidata - wikimedia - TriplyDB

Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a.

Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a.

http://www.wikidata.org/entity/Q42687643

about

Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus Hepatic steatosis: a benign disease or a silent killer Metabolic alterations and hepatitis C: From bench to bedside Chronic hepatitis C virus infection and lipoprotein metabolism Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3 Structural Analysis of Hepatitis C Virus Core-E1 Signal Peptide and Requirements for Cleavage of the Genotype 3a Signal Sequence by Signal Peptide Peptidase Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3 Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Mechanisms and significance of liver steatosis in hepatitis C virus infection Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis.A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.HIV and HAART-Associated Dyslipidemia Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt.Hepatitis C virus infection: Are there still specific problems with genotype 3?Review article: chronic hepatitis C--natural history and cofactors.Hepatitis C and steatosis: a reappraisal.Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.Liver enzyme alterations in HCV-monoinfected and HCV/HIV-coinfected patients Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection.Hepatocellular carcinoma in older adults: clinical features, treatments, and survival.Cholesterol and chronic hepatitis C virus infection.Current understanding of insulin resistance in hepatitis C.Metabolic alterations and chronic hepatitis C: treatment strategies.Lipids and HCV.Is genotype 3 of the hepatitis C virus the new villain?An insight into the diagnosis and pathogenesis of hepatitis C virus infection.Review article: genetic factors that modify the outcome of viral hepatitis.Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.Genotype specific peripheral lipid profile changes with hepatitis C therapy.The association between chronic hepatitis C infection and cardiovascular risk.Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C.Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort.

P2860

Q21090530-F04E970E-41E7-43E3-821A-32E49F0FE2B9 Q22305506-5DB118CB-67FE-40F4-ABAE-60E177FCE95A Q26773261-CBE4D475-DD17-44A7-A0A2-345F5FE8382C Q26784234-B49FE7C7-B429-46B2-9E66-A83E6CB99EC3 Q27478309-9DB8A8CD-E86F-4716-8DD7-3C16042C5B6C Q27478329-DA993BE0-5AD4-4164-B343-2E1DC2665EC8 Q27485351-1D773F68-CABD-4689-A264-45E98937960B Q27679127-38153619-A478-405A-93D3-CD77861705BC Q28732828-FB205D39-AF56-466A-ADD9-2CC601B647C4 Q29417108-956A7CBA-3EE2-4210-90BB-E4FC621B16AB Q30360538-6AF9ACE3-1CB1-44A4-A3AF-DF3B2296B839 Q33866272-0DA6887E-F1FD-4BCD-967C-07E29D7B7AC2 Q34221618-E943A65C-8854-48E1-B9D1-324C456A6A3A Q34341819-563841E4-9649-49AE-96EE-14ABC6D22C9F Q35020217-64D63A49-6449-445C-B172-2453DEDA10D1 Q35259669-8C402644-7F61-4C3A-823F-529408F5F4A2 Q35760270-CE8F7B08-B4F9-40A6-A5B2-F2B21B16D813 Q35956085-289FC6D5-77E4-40AD-81DD-FC23C7592486 Q36269670-1AE45316-A81F-444B-AD2C-B680CB1D147C Q36286336-686E5538-C94F-4DC4-9358-5F6B6F018C98 Q36377276-75C7E475-110D-418F-B7BD-54B995FE3717 Q36712605-1C633862-4D30-4070-9BD3-38C6D9D6BB2C Q37015738-DC353019-A307-4929-AD0D-797F5E1F0FBA Q37063901-7F0E7A5D-64A2-4A1B-B78C-2E47CE0A65B7 Q37308845-0051061B-7FAC-46CF-BE83-9BCB50C46B20 Q37833128-A1EE9CDC-A799-44D6-BEC1-C7752BA5115D Q37891171-1C9D591E-81D7-4C4D-8048-B25A1900D9D9 Q37903853-9D8AA065-C24D-46EE-B2D9-7671745761CA Q37924816-31E1C213-E968-4FB3-B460-E08230842D1E Q38056643-0ECEF6C7-6F6F-475E-B3F3-27CAB8829FB1 Q38155123-D3F0A86E-50E9-4E6A-9819-39EBCCC1BC6B Q38168827-4C1F0380-3535-4934-B0C1-E1A0778414C1 Q38198089-40EA9B2F-CFA1-412A-A38F-830F0859C775 Q39380623-2AB26B90-066E-4F59-BA94-69ED6CC249A0 Q40393590-6F6C6F6A-851E-4D5B-B9F4-F6A7333D8070 Q40947117-AA7583ED-22E6-4B29-9166-D8CDE6EBD6CE Q42282775-179931CB-C0B3-4961-8C51-A48C21566CB1 Q43035013-7DE17CAD-F269-4A1B-813C-29894BC5CAC9 Q43047734-3F72B57A-6221-46A3-B7D5-97ED65AE8B4C Q44101703-67192EC7-BF80-40E2-83BB-6B4E8D699B3E

P2860

Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a.

http://www.wikidata.org/entity/Q42687643

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Hepatocellular fat accumulatio ...... patients infected with HCV-3a.

@en

Hepatocellular fat accumulatio ...... patients infected with HCV-3a.

@nl

type

label

Hepatocellular fat accumulatio ...... patients infected with HCV-3a.

@en

Hepatocellular fat accumulatio ...... patients infected with HCV-3a.

@nl

prefLabel

Hepatocellular fat accumulatio ...... patients infected with HCV-3a.

@en

Hepatocellular fat accumulatio ...... patients infected with HCV-3a.

@nl

P1433

Q42687643-89973809-6AB9-45C2-AECD-F0B858AFBCE9

P1476

Q42687643-CD54566F-911B-4327-9D21-F43CB8AD7617

P2093

Q42687643-196B8213-53BF-4115-8FE4-33EE88C1D0B9

Q42687643-22112EFE-29B5-460A-B18B-2BA19014D1FD

Q42687643-41BF24EF-0997-4836-854D-0979E01F14BE

Q42687643-691514DB-A288-4F54-92B2-999F7EF45296

Q42687643-7CF10D9D-7E96-4076-B453-0F00047D0E33

Q42687643-7ED7271B-D9B7-4299-952C-D245253A6182

Q42687643-983930A1-5ABD-4499-9971-3104982D343F

Q42687643-CCFA76F3-5767-4188-AF18-13106B7CB8B8

P2860

Q42687643-3900B272-DB5C-49E9-920F-3269712FD6B6

Q42687643-58BFA270-5A33-4242-BFDB-A9FF8AA57417

Q42687643-AA61482E-7B7D-4CD7-BD69-BAA6EE5E0B30

Q42687643-AB29170E-E47F-4AAE-850E-6FA8ACFAC697

Q42687643-AE3B1AE6-FE30-469D-8905-66232969B324

Q42687643-B336C9F8-AA5E-45E3-A5B8-4D6DE7434A8A

Q42687643-D52A58C1-8774-41FB-AAAE-4C795897665F

Q42687643-EEE1BEA1-924B-4276-A198-FE02022DD8B6

Q42687643-F8A3D962-5602-4E40-AD31-FE914B14570B

P304

Q42687643-72A5251E-5AC9-4E12-9146-195532BFD21D

P31

Q42687643-02F4BB85-EA1F-4B2B-AF43-F41D999F3C57

P356

Q42687643-3E42C8A3-2E28-46D7-9AF0-8FEDC58D281A

P407

Q42687643-1E7C6767-DF43-4242-8098-6EB1645DB578

P433

Q42687643-3426EF08-CEAC-4961-A224-1D17570AA4F8

P478

Q42687643-0124FEC2-8FF3-4092-9E8E-44EB02B4272E

P50

Q42687643-89F421AA-A2B4-4ED0-A43F-FB39497597A1

P577

Q42687643-68D3801E-4552-4179-9E70-8AFB7298925D

P698

Q42687643-EE09638A-B37E-48F1-89BE-23A215A179E5

P356

J.1572-0241.2002.07056.X

P1433

The American Journal of Gastroenterology

P1476

Hepatocellular fat accumulatio ...... patients infected with HCV-3a.

@en

P2093

Alfred Gangl

http://www.w3.org/2001/XMLSchema#string

Christian Mueller

http://www.w3.org/2001/XMLSchema#string

Christoph Osterreicher

http://www.w3.org/2001/XMLSchema#string

Friedrich Wrba

http://www.w3.org/2001/XMLSchema#string

Hans C Bankl

http://www.w3.org/2001/XMLSchema#string

Harald Hofer

http://www.w3.org/2001/XMLSchema#string

Peter Ferenci

http://www.w3.org/2001/XMLSchema#string

Petra Steindl-Munda

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype.

Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C.

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

P304

2880-2885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2002.07056.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Markus Peck-Radosavljevic

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12425563

http://www.w3.org/2001/XMLSchema#string